Gene · 3853
Papers1,808
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,808
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing. | Int J Mol Sci | 2023 | 36834548 | PubTator, text mining | PubMed |
| Dental Phenotype with Minor Ectodermal Symptoms Suggestive of WNT10A Deficiency. | Children (Basel) | 2023 | 36832485 | PubTator, text mining | PubMed |
| Synergies of Radiomics and Transcriptomics in Lung Cancer Diagnosis: A Pilot Study. | Diagnostics (Basel) | 2023 | 36832225 | PubTator, text mining | PubMed |
| Exfoliative Cytology and Genetic Analysis for a Non-Invasive Approach to the Diagnosis of White Sponge Nevus: Case Series. | Bioengineering (Basel) | 2023 | 36829648 | PubTator, text mining | PubMed |
| Single-cell transcriptome profiling of the stepwise progression of head and neck cancer. | Nat Commun | 2023 | 36828832 | PubTator, text mining | PubMed |
| Identification and vitro verification of the potential drug targets of active ingredients of Chonglou in the treatment of lung adenocarcinoma based on EMT-related genes. | Front Genet | 2023 | 36824434 | PubTator, text mining | PubMed |
| Mutational and Transcriptional Characterization Establishes Prognostic Models for Resectable Lung Squamous Cell Carcinoma. | Cancer Manag Res | 2023 | 36824152 | PubTator, text mining | PubMed |
| Ginsenoside Rg1 as a promising adjuvant agent for enhancing the anti-cancer functions of granulocytes inhibited by noradrenaline. | Front Immunol | 2023 | 36817446 | PubTator, text mining | PubMed |
| Geometric variation of the human tibia-fibula: a public dataset of tibia-fibula surface meshes and statistical shape model. | PeerJ | 2023 | 36811007 | PubTator, text mining | PubMed |
| Establishment of a Lymph Node Metastasis-Associated Prognostic Signature for Lung Adenocarcinoma. | Genet Res (Camb) | 2023 | 36793937 | PubTator, text mining | PubMed |
| Correction to: For whom the bell tolls: psychopathological and neurobiological correlates of a DNA methylation index of time-to-death. | Transl Psychiatry | 2023 | 36792580 | PubTator, text mining | PubMed |
| In silico development and in vitro validation of a novel five-gene signature for prognostic prediction in colon cancer. | Am J Cancer Res | 2023 | 36777511 | PubTator, text mining | PubMed |
| The dual effect of digital communication reinforcement drivers on purchase intention in the social commerce environment. | Humanit Soc Sci Commun | 2023 | 36776351 | PubTator, text mining | PubMed |
| MiR146a-loaded engineered exosomes released from silk fibroin patch promote diabetic wound healing by targeting IRAK1. | Signal Transduct Target Ther | 2023 | 36775818 | PubTator, text mining | PubMed |
| Data-driven identification and classification of nonlinear aging patterns reveals the landscape of associations between DNA methylation and aging. | Hum Genomics | 2023 | 36774528 | PubTator, text mining | PubMed |
| Sialyl LewisX/A and Cytokeratin Crosstalk in Triple Negative Breast Cancer. | Cancers (Basel) | 2023 | 36765690 | PubTator, text mining | PubMed |
| Molecular Pathways of Diabetic Kidney Disease Inferred from Proteomics. | Diabetes Metab Syndr Obes | 2023 | 36760602 | PubTator, text mining | PubMed |
| Parallelized multidimensional analytic framework applied to mammary epithelial cells uncovers regulatory principles in EMT. | Nat Commun | 2023 | 36755019 | PubTator, text mining | PubMed |
| Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myeloma. | JCI Insight | 2023 | 36752202 | PubTator, text mining | PubMed |
| Molecular characterization based on tumor microenvironment-related signatures for guiding immunotherapy and therapeutic resistance in lung adenocarcinoma. | Front Pharmacol | 2023 | 36726580 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3853/papers?page=16